Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Novel ERG for Detection of Hydroxychloroquine Retinopathy

View source ↗

Summary

A clinical trial at King's College Hospital NHS Trust is recruiting to evaluate a novel ERG method for detecting hydroxychloroquine retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plaquenil (hydroxychloroquine)

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Hydroxychloroquine Retinopathy | Status: RECRUITING